期刊文献+

血管内皮生长因子在门静脉高压大鼠腹水形成中的作用 被引量:4

Role of vascular endothelial growth factor on ascites formation in portal hypertensive rats
下载PDF
导出
摘要 目的探讨血管内皮生长因子(VEGF)在门静脉高压大鼠腹水形成中的作用。方法将雄性SD大鼠随机分为3组:门静脉结扎(PVL)组32只,假手术(SO)组16只,门静脉结扎联合沙利度安治疗(PVL-T)组8只。为诱导腹水形成,于手术后第1、3、5、7天分批给予每只大鼠腹腔注射33.33%葡萄糖溶液1mL,30min后收集腹水标本并测总量,同时采用ELISA检测腹水中VEGF含量;留取肠系膜组织作VEGF免疫组化染色和实时RT-PCR检测。结果术后第1、3天PVL组大鼠腹水总量和VEGF含量明显大于SO组(P〈0.05),术后第5、7天PVL组大鼠腹水总量和VEGF含量与SO组比较,差异无统计学意义(P〉0.05),术后第3天PVL-T组腹水总量明显低于PVL组[分别为(3.4±0.27)mL、(4.92±1.53)mL,P〈0.05)]。组织学检查PVL组肠系膜可见较多扩张血管。PVL组VEGF呈强阳性表达,而SO组VEGF则呈弱阳性表达,且表达部位多为血管内皮细胞胞浆;PVL-T组肠系膜VEGFmRNA表达明显降低(P〈0.05)。结论门静脉高压可增加由于渗透性改变所致大鼠腹水形成,VEGF高表达可能与大鼠腹水形成有关。 Objective To study the role of vascular endothelial growth factor on ascites formation in portal hypertensive rats.Methods Male S-D Rats were randomly divided into three groups:portal vein ligation(PVL)group with 32rats,sham-operated(SO)group with 16rats,portal vein ligation combined with thalidomide treatment(PVL-T)group with 8rats.To induce the formation of ascites,1.0mL of 33.33%glucose was injected into abdomen of every rats in 1,3,5,7days after operation.Ascites and mesentery was collected 30minutes after injection of glucose solution.VEGF levels in ascites were measured by ELISA.Expression of VEGF in tissues was studied using real-time RT-PCR and immunohistochemistry.Results 1day,3days after operation,the amount of ascites and VEGF level in PVL rats was significantly higher than that in SO rats(P〈0.05).whereas,5days,7days after operation,the amount of ascites and VEGF concentration had no significant difference between the PVL group and the SO group(P〈0.05).3days after operation,the amount of ascites in PVL-T group was significantly lower than that in PVL group(3.4±0.27 mL vs 4.92±1.53mL,P〈0.05).Histological results showed that Many dilated collateral veins were recognized in the mesentery of PPVL rats.The endothelium of the veins was immunohistochemically strong positive for anti-VEGF in PVL rats.Real-time RTPCR results also showed that VEGF-mRNA expression of mesentery in PVL-T group was significantly lower than that in PVL group(P〈0.05).Conclusion Portal hypertension increases ascites formation which is caused by a difference of osmolality.Increase expression of VEGF may be associated with ascites formation in portal hypertensive rats.Suppression of VEGF activity maybe a new strategy for treatment of refractory ascites in cirrhotic patients.
出处 《重庆医学》 CAS CSCD 北大核心 2010年第16期2105-2107,I0002,共4页 Chongqing medicine
基金 广西壮族自治区卫生厅资助项目(Z2008295)
关键词 血管内皮生长因子 门静脉高压 腹水 肠系膜 沙利度安 vascular endothelial growth factor portal hypertensive ascites mesenteric thalidomide
  • 相关文献

参考文献12

  • 1Moore KP,Aithal GP.Guidelines on the management of ascites in cirrhosis[J].Gut,2006,55(Suppl 6):S1.
  • 2赵永忠,王波,王天才,李德明,周峻峰.血管内皮生长因子在大鼠门脉高压性胃病中的作用初探[J].中华消化杂志,2003,23(3):189-190. 被引量:4
  • 3Groszmann RJ,Vorobioff J,Riley E.Splanchnic hemodynamics in portal-hypertensive rats:measurement with gamma-labeled microspheres[J].Am J Physiol,1982,242(2):156.
  • 4Geerts AM,De Vriese AS,Vanheule E,et al.Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension:an in vivo study[J].Liver Int,2006,26(7):889.
  • 5Fernandez M,Vizzutti F,Garcia-Pagan JC,et al.Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice[J].Gastroenterology,2004,126(3):886.
  • 6Fernandez M,Mejias M,Angermayr B,et al.Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats[J].J Hepatol,2005,43(1):98.
  • 7董晓灵,王曙光,张玉君,江燕.VEGF对大鼠50%减体积肝脏移植术后肝再生的影响[J].重庆医学,2008,37(9):959-961. 被引量:2
  • 8郎明健,曾秋棠,陈波,关思虞.VEGF基因转染乳鼠心肌细胞移植治疗心梗的研究[J].重庆医学,2005,34(11):1669-1672. 被引量:1
  • 9Gupta D,Treon SP,Shima Y,et al.Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion:therapeutic applications[J].Leukemia,2001,15:1950.
  • 10Sauer H,Gunther J,Hescheler J,et al.Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals[J].Am J Pathol,2000,156(1):151.

二级参考文献14

  • 1Hiroaki Shimizu,Noboru Mitsuhashi,Masayuki Ohtsuka,Hiroshi Ito,Fumio Kimura,Satoshi Ambiru,Akira Togawa,Hiroyuki Yoshidome,Atsushi Kato,Masaru Miyazaki.Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats[J].World Journal of Gastroenterology,2005,11(46):7254-7260. 被引量:17
  • 2高力,张曦,陈幸华.肝细胞生长因子与恶性血液病的相关研究进展[J].重庆医学,2006,35(8):746-748. 被引量:2
  • 3Li RK,Jia ZQ,Richard D, et al. Cardiomyocyte transplantation improves heart function[J].Ann Thorac Surg,1996,62:654
  • 4Sakai T,Li RK,Weisel RD,et al.Fetal cell transplantation:a comparison of three cell types[J].J Thorac Cardiovasc Surg,1999,118:715
  • 5Tomita S,Li RK,Weisel RD,et al. Autologous transplantation of bone marrow cells improves damaged heart function[J].Circulation,1999,100(supplⅡ):Ⅱ247
  • 6Hutcheson KA,Atkins BZ,Hueman MT,et al.Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts[J].Cell Transplant,2000,9(3):359
  • 7Tahik O, Brami M, Feldman LJ, et al. The dispatch catheter as a delivery tool for arterial gene transfer[J].Cardiovasc Res,1997,33:181
  • 8Rosengart TK, Lee LY, Patek SR, et al. Angiogenesis gene therapy: phase I assessment of direct intra-myocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease[J].Circulation,1999,100:468
  • 9Tio RA,Tkebuchava T,Scheuermann TH, et al. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardial[J].Hum Gene Ther,1999,10(18):2953
  • 10Suzuki K,Murtuza B,Smolenski RT,et al. Cell transplantation for the treatment of acute myocardial infarction using vascular endothelial growth factor-expressing skeletal myoblasts[J].Circulation,2001,104(12 Suppl 1):1207

共引文献4

同被引文献32

  • 1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:380
  • 2刘成海,张雅丽,冯年平,蔡俊萍,薛惠明,史美育,陈建杰.实胀方与虚胀方辨证敷脐对肝硬化腹水的作用[J].中国中西医结合杂志,2006,26(5):411-414. 被引量:27
  • 3MOORE KP,AITHAL GP.Guidelines on the management of as-cites in cirrhosis[J].Gut,2006,55(S 6):vi1-vi12.
  • 4GROSZMANN RJ,VOROBIOFF J,RILEY E.Splanchnic hemo-dynamics in portal-hypertensive rats:measurement with gam-ma-labeled microspheres[J].Am J Physiol,1982,242(2):156-160.
  • 5MELGAR-LESMES P,TUGUES S,ROS J,et al.Vascular en-dothelial growth factor and angiopoietin-2 play a major role inthe pathogenesis of vascular leakage in cirrhotic rats[J].Gut,2009,58(2):285-292.
  • 6SOHDA T,IWATA K,IRIE M,et al.Characteristic genotypes ofvascular endothelial growth factor are susceptible to ascites inpatients with cirrhosis[J].J Int Med Res,2009,37(3):841-846.
  • 7FERRARA N,HENZEL WJ.Pituitary follicular cells secret anovel heparin-binding growth factor specific for vascular en-dothelial cells[J].Biochem Biophys Res Commun,1989,161(2):851-858.
  • 8FUNYU J,MOCHIDA S,INAO M,et al.VEGF can act as vas-cular permeability factor in the hepatic sinusoids through upregu-lation of porosity of endothelial cells[J].Biochem Biophys ResCommun,2001,280(2):481-485.
  • 9SELGAS R,BAJO A,JIM?NEZ-HEFFERNAN JA,et al.Ep-ithelial-to-mesenchymal transition of the mesothelial cell--itsrole in the response of the peritoneum to dialysis[J].NephrolDial Transplant,2006,21(Supp l 2):ii2-ii7.
  • 10MIZUIRI S,OHASHI Y,HEMMI H,et al.Effects of newperitoneal dialysis solutions,pyridoxamine and AT1 receptorblocker,on TGF-beta1 and VEGF ex pression in rat peritonealmesothelial cells[J].Am J Nephrol,2009,30(3):295.

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部